Keyword: pharmaceuticals

Ethical relationships between doctors and industry 1 April 2010 - 12:00pm

AMA Position Statement on Doctors’ Relationships With Industry 2010

The AMA today released a revised Position Statement to provide guidance to doctors on maintaining ethical relationships with the pharmaceutical industry, the medical device and technology industry, and other care and product suppliers.

The Position Statement on Doctors’ Relationships with Industry 2010 sets out major principles for doctors’ relationships with industry, including managing potential conflicts of interest.

AMA President, Dr Andrew Pesce, said the AMA believes that collaboration between doctors and industry contributes beneficially to the quality of health care that Australians receive.

“However, doctors have a responsibility to ensure that their relationships with industry are consistent with their duties to their patients and to society at large,” Dr Pesce said.

Buprenorphine-naloxone a helpful addition to opioid substitution treatment 2 August 2009 - 12:00pm

MJA Media Release -  Buprenorphine-naloxone a helpful addition to opioid substitution treatment

People who inject drugs may be less likely to inject buprenorphine-naloxone than other opioid substitutes, according to the results of a recent study published in the Medical Journal of Australia.

Buprenorphine is used to treat heroin dependence.

Medicines - 2008 24 June 2008 - 9:00am

AMA Position Statement: Medicines - 2008

Pharmacy Intranet Scheme - 1997 20 January 2003 - 8:00am

AMA Position Statement: Pharmacy Intranet Scheme - 1997

Drugs in Sport - 2000 4 November 2002 - 8:00am

AMA Position Statement: Drugs in Sport - 2000

Use And Misuse Of Medicines And Drugs - 1998 1 January 1998 - 8:00am

AMA Position Statement: Use And Misuse Of Medicines And Drugs - 1998

Syndicate content Syndicate content